Predictors of rehospitalization due to violent behavior in patients with psychotic disorders with a history of violent behavior

既往有暴力行为史的精神病患者因暴力行为再次入院的预测因素

阅读:1

Abstract

BACKGROUND: Some individuals with psychotic disorders may exhibit violent behavior, necessitating psychiatric hospitalization to ensure both patient care and public safety. Understanding factors behind post-discharge rehospitalization due to violence is crucial. This study aims to examine the association between treatment adherence, psychiatric follow-up frequency, and prescribed medications with the risk of violent-behavior-related rehospitalization in patients with psychotic disorders. METHOD: This retrospective cohort study included 68 patients diagnosed with psychotic disorders under mandatory forensic psychiatric follow-up between January 2022 and February 2025. Patients were categorized into two treatment groups: oral antipsychotic treatment and long-acting injectable (LAI) antipsychotic treatment. The primary outcome was rehospitalization due to violent behavior. Binary logistic regression and Cox regression analyses were performed to identify predictors of rehospitalization and treatment adherence. RESULTS: The mean age was 46.76 years. 80.9% of the patients were male, and 70.6% were adherent to treatment. During the follow-up period, 14.7% of the patients were rehospitalized due to violent behavior. Non-adherent patients had a significantly higher risk of rehospitalization (p < 0.001), with a 15-fold increased risk compared to adherent patients. While LAI antipsychotic use, regular follow-up at Community Mental Health Centers, and more frequent psychiatric evaluations were associated with lower rehospitalization rates, these effects did not reach statistical significance. CONCLUSIONS: Treatment adherence is a key factor in preventing rehospitalization due to violent behavior. Given its substantial predictive value, interventions targeting adherence, such as LAI antipsychotic use and psychosocial support, should be prioritized. Future studies should include objective medication adherence measures, long-term follow-up, and additional clinical outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。